BioCorRx (BICX) Total Current Liabilities (2010 - 2026)

BioCorRx has disclosed Total Current Liabilities across 17 years of filings, most recently posting $8.5 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $8.5 million, down 36.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.5 million (down 36.58% YoY), and the FY2025 annual result was $8.3 million, up 1.2% from the prior year.
• Total Current Liabilities came in at $8.5 million for Q1 2026 at BioCorRx, up from $8.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $14.6 million in Q2 2025 to a low of $3667.0 in Q3 2025.
• The 5-year median for Total Current Liabilities is $6.4 million (2023), against an average of $7.0 million.
• Peak annual rise in Total Current Liabilities reached 99.03% in 2025, while the deepest fall reached 99.96% in 2025.
• BioCorRx's Total Current Liabilities stood at $5.4 million in 2022, then climbed by 19.9% to $6.4 million in 2023, then grew by 27.62% to $8.2 million in 2024, then gained by 1.2% to $8.3 million in 2025, then climbed by 2.66% to $8.5 million in 2026.
• The last three Total Current Liabilities figures came in at $8.5 million (Q1 2026), $8.3 million (Q4 2025), and $3667.0 (Q3 2025), per Business Quant data.